InflaRx N.V. Selling Expense
InflaRx N.V. (IFRX) reported Selling Expense of EUR 1.60 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-20.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:SellingExpense · last filed 2025-03-20
| Period end | Selling Expense 12 month |
|---|---|
| 2024-12-31 | 1.60M EUR 20-F · filed 2025-03-20 |
| 2023-12-31 | 1.00M EUR 20-F · filed 2024-03-21 |